CellaVision AB specializes in digital cell morphology, offering a portfolio of analyzers, slide makers, reagents, and software applications. Its flagship products, such as the DM1200, DM9600, and DC-1 analyzers, automate the capture and classification of digital images from blood smears and body fluid preparations. The company generates revenue through a combination of instrument sales and recurring streams from software licenses, reagents, and service contracts. By standardizing the morphological examination process, CellaVision addresses the global shortage of skilled morphologists and enhances laboratory productivity. The company operates through a network of direct sales and distribution partners across the Americas, EMEA, and the Asia-Pacific regions.
